These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9381993)

  • 1. Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl.
    Andrews TC; Whitney EJ; Green G; Kalenian R; Personius BE
    Am J Cardiol; 1997 Oct; 80(7):831-5. PubMed ID: 9381993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.
    Whitney EJ; Krasuski RA; Personius BE; Michalek JE; Maranian AM; Kolasa MW; Monick E; Brown BG; Gotto AM
    Ann Intern Med; 2005 Jan; 142(2):95-104. PubMed ID: 15657157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.
    Warnholtz A; Wild P; Ostad MA; Elsner V; Stieber F; Schinzel R; Walter U; Peetz D; Lackner K; Blankenberg S; Munzel T
    Atherosclerosis; 2009 May; 204(1):216-21. PubMed ID: 18822413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of gemfibrozil, niacin and cholestyramine combination therapy on metabolic syndrome in the Armed Forces Regression Study.
    Krasuski RA; Devendra GP; Cater G; Whitney EJ
    Am J Med Sci; 2011 May; 341(5):378-82. PubMed ID: 21358314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-release niacin/laropiprant improves endothelial function in patients after myocardial infarction.
    Bregar U; Jug B; Keber I; Cevc M; Sebestjen M
    Heart Vessels; 2014 May; 29(3):313-9. PubMed ID: 23712600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
    Guyton JR; Blazing MA; Hagar J; Kashyap ML; Knopp RH; McKenney JM; Nash DT; Nash SD
    Arch Intern Med; 2000 Apr; 160(8):1177-84. PubMed ID: 10789612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A
    Vasc Med; 2014 Feb; 19(1):54-66. PubMed ID: 24391126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired brachial artery endothelial function is not predicted by elevated triglycerides.
    Schnell GB; Robertson A; Houston D; Malley L; Anderson TJ
    J Am Coll Cardiol; 1999 Jun; 33(7):2038-43. PubMed ID: 10362211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression.
    Kuvin JT; Rämet ME; Patel AR; Pandian NG; Mendelsohn ME; Karas RH
    Am Heart J; 2002 Jul; 144(1):165-72. PubMed ID: 12094204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of extended-release niacin on endothelial function in HIV-infected patients on stable antiretroviral therapy.
    Chow DC; Stein JH; Seto TB; Mitchell C; Sriratanaviriyakul N; Grandinetti A; Gerschenson M; Shiramizu B; Souza S; Shikuma C
    AIDS; 2010 Apr; 24(7):1019-23. PubMed ID: 20216298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summaries for patients. Targeting cholesterol treatment toward increasing high-density lipoprotein levels.
    Ann Intern Med; 2005 Jan; 142(2):I46. PubMed ID: 15657152
    [No Abstract]   [Full Text] [Related]  

  • 13. Short-term effects of extended-release niacin with and without the addition of laropiprant on endothelial function in individuals with low HDL-C: a randomized, controlled crossover trial.
    Nasser Figueiredo V; Vendrame F; Colontoni BA; Quinaglia T; Roberto Matos-Souza J; Azevedo Moura F; Coelho OR; de Faria EC; Sposito AC
    Clin Ther; 2014 Jun; 36(6):961-6. PubMed ID: 24768191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of extended-release niacin on serum lipids and on endothelial function in adults with sickle cell anemia and low high-density lipoprotein cholesterol levels.
    Scoffone HM; Krajewski M; Zorca S; Bereal-Williams C; Littel P; Seamon C; Mendelsohn L; Footman E; Abi-Jaoudeh N; Sachdev V; Machado RF; Cuttica M; Shamburek R; Cannon RO; Remaley A; Minniti CP; Kato GJ
    Am J Cardiol; 2013 Nov; 112(9):1499-504. PubMed ID: 24035168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol.
    Sakai T; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1783-9. PubMed ID: 11701466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of chylomicron remnants and impaired vascular reactivity occur in subjects with isolated low HDL cholesterol: effects of niacin treatment.
    Benjó AM; Maranhão RC; Coimbra SR; Andrade AC; Favarato D; Molina MS; Brandizzi LI; da Luz PL
    Atherosclerosis; 2006 Jul; 187(1):116-22. PubMed ID: 16458316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation.
    Dubé MP; Komarow L; Fichtenbaum CJ; Cadden JJ; Overton ET; Hodis HN; Currier JS; Stein JH;
    Clin Infect Dis; 2015 Sep; 61(5):840-9. PubMed ID: 25979307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study.
    Zema MJ
    J Am Coll Cardiol; 2000 Mar; 35(3):640-6. PubMed ID: 10716466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of acute trans-resveratrol supplementation in treated hypertensive patients with endothelial dysfunction.
    Marques BCAA; Trindade M; Aquino JCF; Cunha AR; Gismondi RO; Neves MF; Oigman W
    Clin Exp Hypertens; 2018; 40(3):218-223. PubMed ID: 29431520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a combination of gemfibrozil and niacin on lipid levels.
    Spencer GA; Wirebaugh S; Whitney EJ
    J Clin Pharmacol; 1996 Aug; 36(8):696-700. PubMed ID: 8877672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.